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Human embryonic stem (ES) cells can be induced to dif-
ferentiate into hematopoietic precursor cells via two methods:
the formation of embryoid bodies (EBs) and co-culture with
mouse bone marrow (BM) stromal cells. In this study, the
above two methods have been combined by co-culture of
human ES-cell-derived EBs with human BM stromal cells.
The efficacy of this method was compared with that using EB
formation alone. The undifferentiated human ES cell line
SNUhES3 was allowed to form EBs for two days, then EBs
were induced to differentiate in the presence of a different
serum concentration (EB and EB/high FBS group), or co-
cultured with human BM stromal cells (EB/BM co-culture
group). Flow cytometry and hematopoietic colony-forming as-
says were used to assess hematopoietic differentiation in the
three groups. While no significant increase of CD34+/CD45-
or CD34+/CD38- cells was noted in the three groups on days
3 and 5, the percentage of CD34+/CD45- cells and CD34+/
CD38- cells was significantly higher in the EB/BM co-culture
group than in the EB and EB/high FBS groups on day 10. The
number of colony-forming cells (CFCs) was increased in the
EB/BM co-culture group on days 7 and 10, implying a possible
role for human BM stromal cells in supporting hematopoietic
differentiation from human ES cell-derived EBs. These results
demonstrate that co-culture of human ES-cell-derived EBs with
human BM stromal cells might lead to more efficient hemato-
poietic differentiation from human ES cells cultured alone. Fur-
ther study is warranted to evaluate the underlying mechanism.
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INTRODUCTION
Human embryonic stem (ES) cells have the ca-
pacity to differentiate into multiple tissue lineages,
showing the presence of pluripotent differen-
tiating ability.
1-4 These characteristics suggest that
human ES cells have the potential to provide an
unlimited supply of different cell types for tissue
replacement.
5 However, human ES cells have not
been introduced to clinical practice due to a mul-
titude of biological and ethical limitations. Since
the first bone marrow transplantation, hemat-
opoietic stem cells have been introduced for the
treatment of incurable hematologic disorders.
6,7
However, the sources for hematopoietic stem cells
have been limited to bone marrow (BM), umbilical
cord, and mobilized peripheral blood tissues.
8
Recently, human ES cells have been investigated as
an alternative source for hematopoietic stem cells
because of their pluripotency and capacity to
supply an unlimited number of normal cells. How-
ever, in contrast to other organ systems such as
neuronal differentiation, the mechanism and opti-
mal methods for hematopoietic differentiation from
human ES cells have not been clearly defined.
At present, there are two reported methods for
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the induction of hematopoietic differentiation
from human ES cells. One is the embryoid bodies
(EBs) formation method,
9 and the other is a
co-culture method of human ES cells with a BM
stromal cell line.
10 EBs are a cluster of human ES
cells, and removal of human ES cells from culture
conditions containing basic fibroblast growth fac-
tor (bFGF) results in the aggregation of human ES
cells into EBs.
11 These EBs have the capacity to
differentiate into all three primary germ layers:
endoderm, ectoderm, and mesoderm.
12-14 Diverse
lineages of cells can develop inside EBs, and the
addition of cytokines facilitates hematopoietic dif-
ferentiation.
15,16 On the other hand, co-culture of
human ES cells with a BM stromal cell line, such
as OP9 (OP9 system), has been reported to be an
efficient system for inducing hematopoietic differ-
entiation because the microenvironment surroun-
ding stem cells is important for the differentiation
of stem cells into specific lineages.
10,17
In this study, BM stromal cells were used in-
stead of OP9 stromal cells for co-culture with
human ES cells. When human ES cell-derived EBs
were co-cultured with human BM stromal cells,
better hematopoietic differentiation was observed
than with co-culture of human ES cells with hu-
man BM stromal cells.
18 However, it is not clear
whether hematopoietic differentiation from the
co-culture of EBs with human BM stromal cells is
due to the intrinsic differentiation potential of EBs
or an effect from the microenvironment provided
by the co-culture of EBs with human BM stromal
cells. Although the hematopoietic cell fate of
human ES cells is thought to originate during the
period of EB development, there has been no
report verifying this question.
19 Therefore, this
study has attempted to clarify the role of human
BM stromal cells in the induction of hematopoietic
differentiation from EBs. The SNUhES3 human ES
cell line, which was established from Seoul Natio-
nal University and recently described, was used
for these studies.
20
MATERIALS AND METHODS
Cell culture
The human ES cell line SNUhES3 (obtained
from Seoul National University, Seoul, Korea) was
maintained as undifferentiated cells by culture on
feeder layers of irradiated rat embryonic fibro-
blasts (STO cells, ATCC, USA) in DMEM/F-12
supplemented with 20% Knockout Serum Re-
placer (Invitrogen Corporation, Carlsbad, CA,
USA), 0.1 mM nonessential amino acids (Invi-
trogen), 0.1 mM -merca β ptoethanol, 1% penicil-
lin-streptomycin (Sigma, St. Louis, MO, USA), and
4 ng/mL recombinant human bFGF (Invitrogen).
Undifferentiated SNUhES3 cells were passaged
weekly by dissociation under a microscope and
cultured at 37 , 5% CO2, and 95% humidity.
Human bone marrow stromal cells were obtained
from healthy persons who voluntarily donated
their bone marrow stem cells for stem cell trans-
plantation. Written informed consent was ob-
tained from all the donors before bone marrow
harvest. The institutional review board of Korea
University Medical Center approved this study
protocol. Human bone marrow stromal cells were
grown and maintained before starting co-culture
with embryoid bodies in low glucose DMEM
(Invitrogen) containing 10% fetal bovine serum
(FBS), and 1% penicillin-streptomycin. For co-cul-
ture with embryoid bodies, human bone marrow
stromal cells were irradiated (1500 cGy) before
being transferred to plates.
Formation of embryoid bodies and co-culture
with human bone marrow stromal cells
Undifferentiated SNUhES3 cells were scraped
off and transferred to low-adherence tissue cul-
ture plates (Corning Costar Corporation, Acton,
MA, USA) to prevent attachment. Embryoid
bodies (EBs) were formed two days after trans-
ferred SNUhES3 cells were cultured in serum-
containing differentiation media: DMEM/F12 sup-
plemented with 20% non-heat inactivated FBS, 1%
nonessential amino acids, 0.1 mM β-mercaptoe-
thanol, and 1% penicillin-streptomycin (Sigma).
Formed EBs were either maintained in the above
serum-containing differentiation media (EB group)
or transferred into differentiation media conta-
ining a high concentration of serum (EB/high FBS
group): DMEM/F12 supplemented with 40% FBS,
1% nonessential amino acids, 0.1 mM -mer β cap-
toethanol, and 1% penicillin-streptomycin. MediaHematopoietic Differentiation of Human Embryonic Stem Cells
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were changed every 2 to 3 days in both groups
until the 10th days of culture.
After two days of culture in serum-containing
differentiation media, EBs were transferred onto
irradiated human bone marrow stromal cell layers
and cultured with differentiation media composed
of IMDM (Invitrogen Corporation, Carlsbad, CA,
USA) supplemented with 12.5 FBS, 12.5% horse
serum, L-glutamine, and 1% penicillin-strepto-
mycin (EB/BM co-culture group). Media were
changed every 2 to 3 days until the 10th days of
culture. After the indicated days from the start of
EB formation culture (days 3, 5, 7 and 10), EB-
derived differentiated cells were harvested, made
into single cell suspensions, and analyzed by flow
cytometry and colony-forming cell assays. Hema-
topoietic differentiation was compared among
these three groups: EB, EB/high FBS and the EB/
BM co-culture group (Fig. 1).
Flow cytometry
The mixture of EB-derived differentiated cells
was dissociated with 1 mg/mL collagenase type
IV (Invitrogen Corporation, Carlsbad, CA, USA)
followed by 0.05% trypsin/0.53 mM EDTA sup-
plemented with 2% chick serum (Invitrogen). Dis-
sociated cells were filtered through 85 μM nitex
mesh to remove remaining clumps. Single- cell
suspensions of EB-derived cells were washed with
phosphate-buffered saline (PBS) supplemented
with 2% FBS and 0.1% sodium azide. The cells
were then incubated with antibodies against
human blood cell antigens. First, the single-cell
suspensions were stained with CD34- FITC and
CD45-PE monoclonal antibodies (Beckman Coul-
ter, Fullerton, CA, USA). After incubation in the
dark at 4 for 25 minutes, the fraction of CD34+/
CD45-cells was detected and analyzed with
Cell-Quest Pro Software (Becton-Dickinson, San
Jose, CA, USA). Second, the single-cell suspensions
were stained with CD34-FITC and CD38-PE mono-
clonal antibodies (Beckman Coulter, Fullerton, CA,
USA). The percentages of CD34+/CD45- and
CD34+/CD38-cells were compared among the
three groups at each time point.
Fig. 1. Schematic for the comparison of the
EB, EB/high FBS, and EB/BM co-culture
groups. Undifferentiated human ES cells at
confluence were scraped off and transferred
to low-attachment plates in differentiation
medium. In the EB group, human ES cells
were cultured for EB formation in differen-
tiation medium for 10 days. The EB/high
FBS group was cultured for 10 days in the
same culture media supplemented with
20% FBS. The EB/BM co-culture group was
a co-culture of EBs with human BM stromal
cells.Seok Jin Kim, et al.
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Hematopoietic colony-forming assays
After culturing for the indicated number of
days (7 and 10), single-cell suspensions were pre-
pared from EB-derived differentiated cells in the
three groups as described above. Colony-forming
assays were performed by culturing 1 × 10
5 of
these cells in semi-solid Methocult H4444 media
(StemCell Technologies, BC, Canada) composed of
1% methylcellulose, 30% FBS, 1% bovine serum
albumin (BSA), 50 ng/mL human stem cell factor,
10 ng/mL human granulocyte-macrophage col-
ony-stimulating factor, 10 ng/mL human interleu-
kin-3, and 3 units/mL erythropoietin. After 14
days of culture in a humidified incubator at 37
and 5% CO2, the plates were scored for colony-
forming cells (CFCs) using inverted microscope
and gridded scoring dishes based on the standard
criteria of manufacturer's atlas.
Statistical analysis
All data are presented as mean ± SEM and
statistical significance was determined using a
one-way ANOVA test. Results were considered
significant when the p value was less than 0.05.
RESULTS
There was no significant difference in the per-
centage of CD34+/CD45-cells among the three
groups on days 3 and 5. However, on day 7, an
increase in the percentage of CD34+/CD45- cells
was found in the EB/BM co-culture group. On
day 10, the percentage of CD34+/CD45- cells
(3.80% ± 0.58) was significantly higher in EB/BM
co-culture group than in EB and EB/high FBS
groups (p < 0.05, Fig. 2). Even after 10 days of cul-
ture, the percentage of CD34+/CD45- cells was
not significantly changed in EB and EB/high FBS
groups (0.28% ± 0.23 and 0.35% ± 0.11, respec-
tively). In the three groups, the percentage of
CD34-/CD45+ cells and CD34+/CD45+ cells were
less than 0.10% regardless of culture duration.
The number of CD34+/CD38- cells increased on
day 5 in the EB/BM co-culture group (Fig. 3). The
percentage of CD34+/CD38- cells in EB/BM co-
culture group (5.81% ± 1.19) was significantly
higher than the EB and EB/high FBS groups on
days 5, 7, and 10 (p < 0.05, Fig. 2). There was no
significant change in the percentage of CD34+/
CD38- cells in the EB and EB/high FBS groups
throughout the period of culture. In all of the
three groups, the percentage of CD34-/CD38+
cells and CD34+/CD38+ cells was also less than
0.10% on the indicated days of culture (days 3, 5, 7,
and 10). This time course analysis showed the
correlation between CD34+/CD45- cells and CD34+/
CD38- cells and also demonstrated that co-culture
with human BM stromal cells might increase the
hematopoietic differentiation of human ES cells.
On days 7 and 10, when a significant increase of
CD34+/CD45-/CD38- cells was observed, cul-
tured cells were harvested for colony-forming
assays. In the EB and EB/high FBS groups, the
mean number of colony-forming cells (CFCs) per
10
5 cells was not significantly changed on days 7
Fig. 2. The percentage of CD34+/CD45- cells (top) and
CD34+/CD38- cells (bottom) was significantly higher in
the EB/BM co-culture group than in the EB and EB/FBS
groups (p < 0.05).Hematopoietic Differentiation of Human Embryonic Stem Cells
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and 10 (Fig. 4). However, the number of CFCs per
10
5 cells was increased in EB/BM co-culture on
days 7 and 10 (11.0 ± 5.14, 20.6 ± 7.40, respec-
tively), implying a possible role of human BM
stromal cells for supporting hematopoietic dif-
ferentiation from human ES-cell-derived EBs.
DISCUSSION
The advancement of cell culture techniques has
allowed various kinds of in vitro studies and a
better understanding of stem cell biology.
21-23 In
spite of substantial biological and ethical limita-
tions, human ES cells might be a useful candidate
for the source of normal cells in clinical practice
because of their pluripotency and the presence of
established human ES cell lines. In our previous
report, a greater number of CD34+/CD45- cells
was found when EBs were co-cultured with
human BM stromal cells than when undifferen-
tiated human ES cells were co-cultured with
human BM stromal cells.
18 However, this report
had not defined whether the observed hemato-
poietic differentiation was mainly due to EB for-
mation itself or due to an effect of the co-culture
of EBs with human BM stromal cells. Moreover,
there has been a recent paper reporting that a
subpopulation responsible for hematopoietic and
endothelial development was demonstrated inside
EBs, suggesting that EBs possess hemangioblastic
properties.
19
To discriminate between the co-culture effect of
EBs with human BM stromal cells and the effect
of embryoid body itself on hematopoietic differ-
entiation, we compared the expression of CD34,
CD38 and CD45 in the co-culture of EBs and
human BM stromal cells (EB/BM co-culture group)
and EBs alone (EB group) after the same planned
period of culture. In addition, considering that
additional FBS was added to the media for co-
culture with human BM stromal cells in ours and
other previous studies, EBs were also cultured with
the addition of 20% FBS (EB/high FBS group).
24,25
In this comparison, the percentage of CD34+/
CD45- cells was higher in the EB/BM co-culture
group than in the EB and EB/high FBS groups, and
there was no significant difference between the EB
and EB/high FBS groups. Furthermore, the
percentage of CD34+/CD38- cells was also higher
Fig. 3. Flow cytometry of CD34+/CD38- cells shows the number of CD34+/CD 38- cells increased on day 5 and 10
in the EB/BM co- culture group.
Fig. 4. The number of CFCs per 10
5 cells was increased
in the EB/BM co-culture group on days 7 and 10 (11.0
± 5.14, 20.6 ± 7.40, respectively), while there was no
change in the EB and EB/high FBS groups.Seok Jin Kim, et al.
Yonsei Med J Vol. 46, No. 5, 2005
in the EB/BM co-culture group, consistent with the
results of the CD34+/CD45- staining experiments.
In colony-forming assays, a significant increase
in the number of colony-forming cells was ob-
served in the cells derived from co-culture of EBs
with human BM stromal cells (EB/BM co-culture
group), especially on days 7 and 10. These results
suggest that an appropriate microenvironment
provided by co-culture with human BM stromal
cells may be more important for human ES cell-
derived hematopoietic differentiation than the
differentiation potential of EBs. In the past, the
stromal cells used, such as OP9, originated from
animals. However, murine stromal cells may pro-
voke unwanted effects in human ES cells because
of species differences. Thus, co-culture with hu-
man BM stromal cells seems the best plan, but has
rarely been tried. This study has demonstrated
that the use of human BM stromal cells might be
as effective of a culture condition as murine BM
stromal cells that were previously reported.
26 Our
study seems to be the first report showing that
human BM stromal cells can offer the correct
microenvironment for hematopoietic differentia-
tion of EBs.
In summary, the microenvironment provided
by co-culture with human BM stromal cells may
play a role inducing the hematopoietic differen-
tiation of human EBs. Therefore, co-culture of
EBs with human BM stromal cells might be a
feasible way for promoting hematopoietic dif-
ferentiation of human ES cells. However, because
we have used only one human ES cell line, fur-
ther studies are warranted with different human
ES cell lines.
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